|
Consent
ALL patients receiving a transfusion of red blood cells, platelets, fresh frozen plasma and cryoprecipitate shall provide written consent on the Blood Transfusion form M109.0. Prior to blood transfusion, staff should ensure that the patient has given written consent. The date of any previous consent to blood transfusion shall be documented on the consent form M109.0. This can be used as a guide to locate a previous consent and determine validity.
Blood Transfusion form M109.0
Blood Consent Instructions
Frequency of Consent
Acute patients: For patients receiving a blood transfusion associated with surgery or a medical condition, consent is valid for the admission.
Chronic patients: Patients whose treatment program involves regular blood transfusion e.g. haematology, oncology, renal, liver unit, consent is valid for 12 months. Consent shall be reviewed earlier if alternative treatments become available or new risks associated with the supply of blood are identified.
Emergency Transfusions: will be administered if there is no evidence that the patient has objected to blood transfusion.
Patients who Refuse Blood Components and Blood Products
Some patients refuse blood and blood products, in particular, Jehovah’s Witnesses have specific religious beliefs regarding transfusion and their acceptance of particular products may vary (e.g. albumin may be acceptable). A fully informed, competent adult patient is entitled to decide to accept medical treatment or not. Refer to hospital policy on the Management of Patients who Refuse Blood and Blood Products
Clinician Responsibilities
Medical officers are responsible for obtaining and documenting informed consent to blood transfusion.
Nursing staff are responsible for ensuring there is evidence of written consent prior to blood transfusion and notifying the medical officer is there is any change in the patient’s wishes.
Guide to Informing Patients of Blood Transfusion
-
Explain the reason for blood transfusion
-
Explain the type of blood component/product and expected outcome
-
Explain the risks of transfusion. See link to the Transfusion Medicine Manual below
-
Available alternatives
-
Provide a patient information brochure, available in multiple languages. See links below.
-
Provide the patient with an opportunity to ask questions
-
Document the consent on the Blood Transfusion form M109.0
Risks associated with Transfusion
Transfusion Medicine Manual Blood Service
Back to top
Patient Information - Adult
Austin Health Patient Information Site
Patient information - ENGLISH
Patient information - ARABIC
Patient information - CROATIAN
Pateint information - GREEK
Patient information - ITALIAN
Patient information - KOREAN
Patient information - SPANISH
Patient information - TURKISH
Patient information - VIETNAMESE
Albumex 4 Consumer Information
Albumex 20 Consumer Information
Back to top
Patient Information - Paediatric
Billy Blood Drop
Parent's Guide
Policy Links
Management of Patient who Refuse Blood and Blood Products
Consent (Informed) to Diagnosis and Treatment
Prescription Form
Prescribing a blood component or blood product transfusion is the responsibility of the medical officer or a nurse practitioner if included within their scope of practice.
ALL blood transfusions, including blood products e.g. Albumin, Immunoglobulins and Factor Concentrates, shall be prescribed on the Blood Transfusion form M109.0.
Blood Transfusion form M109.0
Prescription for blood transfusion shall include:
-
Patient's FULL name, UR number and date of birth
-
Type of blood component/product, including modification i.e. irradiation, CMV negative
-
Dose. Do not abbreviate the word "unit".
-
Duration of transfusion. Do not use the acronym app (as per protocol).
-
Additional instructions. If medication is required before or during the transfusion episode, this must be prescribed on the hospital medication chart.
-
The prescriber's signature and name
Back to top
NHMRC Guidelines
Austin Health has endorsed the use of the Clinical Practice Guidelines on the use of blood components, developed by the NHMRC/ANZSBT. See Blood Component Transfusion clinical guideline.
Click the link for further information about blood components and products.
|